article thumbnail

Beyond the Lab: Cell & Gene Therapy

Drug Target Review

Dear Readers, I am thrilled to announce the launch of our new series, “Beyond the Lab,” which promises to deliver high-level insights commissioned exclusively by Drug Target Review magazine. By staying up to date with these developments, readers will be able to anticipate future advancements and understand their potential impact.

article thumbnail

Let’s talk neuroscience with Michelle Sidor at SFN

Drug Target Review

We focus on patients who are resilient to disease and conduct an unbiased search for protective autoantibodies in these patients that may underlie their resiliency. There is a huge push for multiplexed biological readouts, coupled with more advanced translatable model systems that capture more of the complexity of human neurological diseases.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tony Bennett’s Struggle With Alzheimer’s Revealed

The Pharma Data

1, 2021 — As Tony Bennett releases what may well be his last album, his family has disclosed that the 1950s crooner who became popular with younger audiences decades later has Alzheimer’s disease. His wife, Susan, made the announcement in an interview published in AARP magazine. MONDAY, Feb.

Doctors 52
article thumbnail

GLOBAL BIOTECHNOLOGY LEADER AMGEN BREAKS GROUND ON NEW MANUFACTURING FACILITY IN NORTH CAROLINA

The Pharma Data

The facility, expected to be operational by 2025, will support the growing demand for Amgen’s medicines that treat serious illnesses such as cancer and heart disease. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Science 52
article thumbnail

Mediating BRAF-mutant melanoma resistance

Drug Target Review

Her research focus is on epigenetic regulation of melanoma and other cancers as well as wound healing, ageing biology and the development of novel epigenetic therapies targeting cancers and skin diseases and she is the owner of 15 issued and pending patents relevant to her research.

article thumbnail

Regeneron Once Again Earns #1 Ranking in Science Magazine’s Top Biopharma Companies to Work For

The Pharma Data

NASDAQ: REGN ) today announced that the company was once again ranked as the top company to work for by Science magazine in its annual Top Employers Survey of the global biotech and pharmaceutical industry. Regeneron has been consistently ranked #1 or 2 Top Employer for past 10 years. Regeneron Pharmaceuticals, Inc.

Science 40
article thumbnail

Using AI to Find New Antibiotics Still a Work in Progress

NIH Director's Blog: Drug Discovery

AlphaFold’s AI-powered ability to predict protein structures was a finalist in Science Magazine ’s 2020 Breakthrough of the Year. Centers for Disease Control and Prevention. [2] In the latest study, Collins and his team looked to an AI program called AlphaFold2 [3]. The name might ring a bell.

Doctors 52